Taal M - Search Results

1

Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats.

Laskowski IA, Pratschke J, Wilhelm MJ, Dong VM, Beato F, Taal M, Gasser M, Hancock WW, Sayegh MH, Tilney NL. Laskowski IA, et al. Among authors: taal m. J Am Soc Nephrol. 2002 Feb;13(2):519-527. doi: 10.1681/ASN.V132519. J Am Soc Nephrol. 2002. PMID: 11805183

2

Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.

Mackenzie HS, Ziai F, Omer SA, Nadim MK, Taal MW. Mackenzie HS, et al. Among authors: taal mw. J Am Soc Nephrol. 1999 Apr;10 Suppl 12:S283-6. J Am Soc Nephrol. 1999. PMID: 10201884 Review.

3

Activation of the heart by donor brain death accelerates acute rejection after transplantation.

Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, Tilney NL. Wilhelm MJ, et al. Among authors: taal m. Circulation. 2000 Nov 7;102(19):2426-33. doi: 10.1161/01.cir.102.19.2426. Circulation. 2000. PMID: 11067799

4

Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone.

Taal MW, Nenov VD, Wong W, Satyal SR, Sakharova O, Choi JH, Troy JL, Brenner BM. Taal MW, et al. J Am Soc Nephrol. 2001 Oct;12(10):2051-2059. doi: 10.1681/ASN.V12102051. J Am Soc Nephrol. 2001. PMID: 11562403

5

Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection.

Wilhelm MJ, Pratschke J, Beato F, Taal M, Laskowski IA, Paz DM, Schmid C, Hancock WW, Scheld HH, Tilney NL. Wilhelm MJ, et al. Among authors: taal m. Transplant Proc. 2002 Sep;34(6):2359-60. doi: 10.1016/s0041-1345(02)03283-9. Transplant Proc. 2002. PMID: 12270436 No abstract available.

6

ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models.

Taal MW, Brenner BM. Taal MW, et al. J Hum Hypertens. 1999 Jan;13 Suppl 1:S51-6; discussion S61. doi: 10.1038/sj.jhh.1000742. J Hum Hypertens. 1999. PMID: 10076921 Review.

7

Multi-hit nature of chronic renal disease.

Nenov VD, Taal MW, Sakharova OV, Brenner BM. Nenov VD, et al. Among authors: taal mw. Curr Opin Nephrol Hypertens. 2000 Mar;9(2):85-97. doi: 10.1097/00041552-200003000-00001. Curr Opin Nephrol Hypertens. 2000. PMID: 10757212 Review. No abstract available.

8

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

Taal MW, Brenner BM. Taal MW, et al. Kidney Int. 2000 May;57(5):1803-17. doi: 10.1046/j.1523-1755.2000.00031.x. Kidney Int. 2000. PMID: 10792600 Free article. Review.

9

Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression.

Taal MW, Omer SA, Nadim MK, Mackenzie HS. Taal MW, et al. Curr Opin Nephrol Hypertens. 2000 Jul;9(4):323-31. doi: 10.1097/00041552-200007000-00001. Curr Opin Nephrol Hypertens. 2000. PMID: 10926167 Review.

10

Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney.

Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS. Taal MW, et al. Kidney Int. 2000 Oct;58(4):1664-76. doi: 10.1111/j.1523-1755.2000.00327.x. Kidney Int. 2000. PMID: 11012900 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters